Firefly Neuroscience Closes on Financing of up to $12.4 Million
Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients ...
Pharmaceutical Technology5d
Iluzanebart by Vigil Neuroscience for Unspecified Neurologic Disorders: Likelihood of Approval
Iluzanebart is under clinical development by Vigil Neuroscience and currently in Phase I for Unspecified Neurologic Disorders.
Nasdaq11d
Firefly Neuroscience Closes $12.4 Million Financing to Support Growth and Commercialization of Brain Network Analytics Technology
Through partnering with neuroscience pharmaceutical companies and by supporting US neurologists and psychiatrists in the diagnosis and optimization of patient care, we are driven to improve ...
Yahoo Finance11d
Firefly Neuroscience Closes on Financing of up to $12.4 Million
Through partnering with neuroscience pharmaceutical companies and by supporting US neurologists and psychiatrists in the diagnosis and optimization of patient care, we are driven to improve ...